ASSOC FOR DIAGNOSTICS & LAB MEDICINE (FKA AM ASSOC OF CLINICAL CHEMISTRY)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2022–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	1	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
Polsinelli PC	—	15

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	14
SENATE	14
Centers For Medicare and Medicaid Services (CMS)	3
Food & Drug Administration (FDA)	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	15

Bills Explicitly Cited (1)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2471117th Congress

Consolidated Appropriations Act, 2022

2022 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

-Laboratory developed testing -Precision Medicine Initiative -Laboratory Testing Harmonization -Labor/HHS/Ed Annual Appropriations -Pediatric Reference Ranges for Laboratory Testing - Verifying Accurate Leading-edge IVCT Development (VALID) Act -H.R.2471 - Consolidated Appropriations Act, 2022

Client expense: — · Firm income: $20,000

Matched citations: H.R.2471

Source: Senate LDA

ASSOC FOR DIAGNOSTICS & LAB MEDICINE (FKA AM ASSOC OF CLINICAL CHEMISTRY) — Lobbying Disclosure | Poliscope